Detalhe da pesquisa
1.
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.
Mol Cell;
78(6): 1096-1113.e8, 2020 06 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32416067
2.
Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma.
Oncotarget;
7(34): 54583-54595, 2016 Aug 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27409346